Short Interest in Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Expands By 1,294.2%

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the target of a large increase in short interest during the month of April. As of April 30th, there was short interest totaling 25,208 shares, an increase of 1,294.2% from the April 15th total of 1,808 shares. Based on an average daily trading volume, of 10,871 shares, the days-to-cover ratio is currently 2.3 days.

Cardio Diagnostics Stock Performance

Shares of CDIOW stock traded down $0.00 during mid-day trading on Wednesday, reaching $0.01. 34,618 shares of the stock traded hands, compared to its average volume of 50,201. The stock’s fifty day simple moving average is $0.02 and its two-hundred day simple moving average is $0.02. Cardio Diagnostics has a 1-year low of $0.01 and a 1-year high of $0.07.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.